Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Peripheral Nervous System Diseases 5 Lymphoma 5 Head and Neck Neoplasms 4 Breast Neoplasms 4 Neoplasms 3 Lymphoma, Large B-Cell, Diffuse 3 Colorectal Neoplasms 3 Stomatitis 2 Stomach Neoplasms 2 Sarcoma 2 Pain 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Mucositis 2 Malnutrition 2 Wilms Tumor 1 Vaso-Occlusive Crises 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcopenia 1 Recurrence 1 Radiation Injuries 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Oral Complications 1 Neurotoxicity Syndromes 1 Neoplasms, Plasma Cell 1 Multiple Endocrine Neoplasia Type 1 1 Malignant mesenchymal tumor 1

Interventions

Irinotecan 10 Fluorouracil 10 Leucovorin 9 Bevacizumab 9 Gemcitabine 8 Paclitaxel 7 Cisplatin 7 Capecitabine 7 Oxaliplatin 6 130-nm albumin-bound paclitaxel 6 Albumin-Bound Paclitaxel 5 napabucasin 4 Sorafenib 4 Drug Therapy 4 Cetuximab 4 pembrolizumab 3 apatinib 3 Radiotherapy 3 Ocoxin 3 Imatinib Mesylate 3 Folfox protocol 3 Everolimus 3 tislelizumab 2 spartalizumab 2 palbociclib 2 entinostat 2 encorafenib 2 camrelizumab 2 anlotinib 2 Sunitinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Digestive System Neoplasms × Glutamine × Clear all

NCT01552291 2018-02-13

Glutaminprojec

Insel Gruppe AG, University Hospital Bern

Phase 4 Completed

Gastrointestinal

Digestive System Neoplasms, Malnutrition

Data powered by HemOnc (CC BY 4.0) Colophon ⚡